Social networking docs write more scripts: eMarketing

Share this article:
Physicians involved in social networking communities online tend to write more prescriptions than other physicians, according to a presentation given at CBI's 8th annual Forum on eMarketing.

Even so, Craig Edfort, senior manager, e-marketing, relationship marketing, strategic business development at Novo Nordisk, said that “selling management without hard ROI is a difficult task,” so digital marketers must be prepared to justify paid executions in the social networking realm. 

Edfort added that Sermo, the largest online physicians' network, is “allow[ing] pharma to participate in a very structured role.” Also, physicians that currently use social networks, or are interested in doing so, are primarily men, explained Bonnie Southcott, interactive producer at Toolhouse Design Co. 

Of the physicians using social networks, 68% are male and 32% are female. Seventy percent of male physicians say they are interested in using social networks, compared with 24% of females, said Southcott, adding that podcasts audiences are currently skewing toward young men as well.

In a separate panel, Thomas McDonnell, director of marketing for Shire's ADHD treatment Intuniv, acknowledged the importance of social networks for physicians, but said that pharma should not be providing the networks themselves. “I don't think it's a business proposition for pharma,” he said. “It's not our role to provide that forum. Our role isn't necessarily to facilitate the conversation [between doctors]. We listen to it, but we should be focused on making sure that physicians have top quality information.”

Glen Butcher, director, global online channel strategies at Merck, agreed with McDonnell, and emphasized the importance of offline support, in the form of accurate, up-to-date drug information. Mark Karch, EVP, business development at Physicians Interactive, predicted that e-prescribing will eventually gain traction, noting that the Obama administration is pumping dollars into e-prescribing. “The scale isn't there yet, but it's coming,” he said.
CBI's eMarketing Forum was held in Princeton, NJ, on March 10-11. 
Share this article:

Next Article in Features

Email Newsletters

More in Features

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...

Read the complete August 2014 Digital Edition

Read the complete August 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.